Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use Recall: Subpotent
Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis…
What is the FDA recall status?
The FDA record lists this recall as ongoing. FDA enforcement data is not a live recall-lifecycle tracker. Follow the official instructions and check the agency notice or firm for current guidance.
Why was Oxytocin 30 Units/500 mL recalled?
Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
What should I do if I have this product?
Follow the firm and FDA instructions for the affected product. Contact the recalling firm for current guidance.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare your product with the product description and available lot, UPC or model codes below from the official FDA record to check whether it is covered by this recall. If an identifier is missing or unclear, check the complete official notice or contact the firm; an incomplete match here does not establish that your product is unaffected.
Full product description
Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1
Which lot codes, UPCs or models are affected?
Lot #: 20250620OXY-1, Expiration date 10/18/2025
- Agency record number
- D-0015-2026
- Product
- Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis…
- Recalling firm
- IntegraDose Compounding Services LLC
- Quantity
- 853/500 mL bags
- Distribution
- Nationwide in the USA
- Recall started
- September 16, 2025
- Report date
- October 22, 2025
- Classification
- Class I
- Status
- Ongoing
- Agency
- FDA (drug)